BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 23773036)

  • 1. Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.
    Dwivedi M; Laddha NC; Mansuri MS; Marfatia YS; Begum R
    Br J Dermatol; 2013 Nov; 169(5):1114-25. PubMed ID: 23773036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo.
    Imran M; Laddha NC; Dwivedi M; Mansuri MS; Singh J; Rani R; Gokhale RS; Sharma VK; Marfatia YS; Begum R
    Br J Dermatol; 2012 Aug; 167(2):314-23. PubMed ID: 22512783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population.
    Jin Y; Birlea SA; Fain PR; Spritz RA
    J Invest Dermatol; 2007 Nov; 127(11):2558-62. PubMed ID: 17637824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of FOXP3 and GAGE10 promoter polymorphisms and decreased FOXP3 expression in regulatory T cells with susceptibility to generalized vitiligo in Gujarat population.
    Giri PS; Patel S; Begum R; Dwivedi M
    Gene; 2021 Feb; 768():145295. PubMed ID: 33181260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic association of NALP1 with generalized vitiligo in Jordanian Arabs.
    Alkhateeb A; Qarqaz F
    Arch Dermatol Res; 2010 Oct; 302(8):631-4. PubMed ID: 20574744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variations of NLRP1: susceptibility in psoriasis.
    Ekman AK; Verma D; Fredrikson M; Bivik C; Enerbäck C
    Br J Dermatol; 2014 Dec; 171(6):1517-20. PubMed ID: 24909542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in NLRP1 gene and susceptibility to autoimmune thyroid disease.
    Alkhateeb A; Jarun Y; Tashtoush R
    Autoimmunity; 2013 May; 46(3):215-21. PubMed ID: 23374100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A coding variant in NLRP1 is associated with autoimmune Addison's disease.
    Zurawek M; Fichna M; Januszkiewicz-Lewandowska D; Gryczyńska M; Fichna P; Nowak J
    Hum Immunol; 2010 May; 71(5):530-4. PubMed ID: 20152874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus.
    Pontillo A; Girardelli M; Kamada AJ; Pancotto JA; Donadi EA; Crovella S; Sandrin-Garcia P
    Autoimmunity; 2012 Jun; 45(4):271-8. PubMed ID: 22235789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP1 haplotypes associated with leprosy in Brazilian patients.
    Pontillo A; Laurentino W; Crovella S; Pereira AC
    Infect Genet Evol; 2013 Oct; 19():274-9. PubMed ID: 23770116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Nod-like receptor protein-1 (rs2670660) and Toll-like receptor-4 (rs4986790) with non-segmental vitiligo: A case-control study in South Indian population.
    Rajendiran KS; Rajappa M; Chandrashekar L; Thappa DM
    Int J Immunogenet; 2019 Oct; 46(5):321-330. PubMed ID: 31293094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NALP1/NLRP1 genetic variants are associated with Alzheimer disease.
    Pontillo A; Catamo E; Arosio B; Mari D; Crovella S
    Alzheimer Dis Assoc Disord; 2012; 26(3):277-81. PubMed ID: 21946017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the association between
    Li J; Yan M; Zhang Y; Feng C; Wang H; Wang C; Sun L
    Oncotarget; 2017 Oct; 8(50):88179-88188. PubMed ID: 29152150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association of nuclear factor of activated T cells' 3'UTR and structural polymorphisms with susceptibility to generalized vitiligo in Gujarat population.
    Giri P; Bhimani R; Patil S; Dwivedi M
    Gene; 2023 Sep; 880():147629. PubMed ID: 37429370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRP1 gene polymorphism influences gene transcription and is a risk factor for rheumatoid arthritis in han chinese.
    Sui J; Li H; Fang Y; Liu Y; Li M; Zhong B; Yang F; Zou Q; Wu Y
    Arthritis Rheum; 2012 Mar; 64(3):647-54. PubMed ID: 21976003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NLRP1, PTPN22 and PADI4 gene polymorphisms and rheumatoid arthritis in ACPA-positive Singaporean Chinese.
    Goh LL; Yong MY; See WQ; Chee EYW; Lim PQ; Koh ET; Leong KP;
    Rheumatol Int; 2017 Aug; 37(8):1295-1302. PubMed ID: 28653215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat.
    Jadeja SD; Mansuri MS; Singh M; Dwivedi M; Laddha NC; Begum R
    PLoS One; 2017; 12(7):e0180958. PubMed ID: 28700671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine-mapping of vitiligo susceptibility loci on chromosomes 7 and 9 and interactions with NLRP1 (NALP1).
    Jin Y; Riccardi SL; Gowan K; Fain PR; Spritz RA
    J Invest Dermatol; 2010 Mar; 130(3):774-83. PubMed ID: 19727120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of increased MYG1 expression and its promoter polymorphism with disease progression and higher susceptibility in vitiligo patients.
    Dwivedi M; Laddha NC; Begum R
    J Dermatol Sci; 2013 Sep; 71(3):195-202. PubMed ID: 23706493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The catalase gene promoter and 5'-untranslated region variants lead to altered gene expression and enzyme activity in vitiligo.
    Mansuri MS; Jadeja SD; Singh M; Laddha NC; Dwivedi M; Begum R
    Br J Dermatol; 2017 Dec; 177(6):1590-1600. PubMed ID: 28542879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.